Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Sushil Kumar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5745-1270; OpenAlex author ID A5005931876. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 8

  1. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217097↗
  2. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2024.101146↗
  3. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
  4. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1128/mcb.00135-21↗
  5. Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-21-1591↗
  6. Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. Last author DOI 10.1016/j.trsl.2018.12.008↗
  7. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. First author DOI 10.1007/978-1-4939-7665-2_9↗
  8. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. First author DOI 10.1038/onc.2016.119↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 6 shared papers, 2016–2024 · strength 0.83
  2. Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2016–2024 · strength 0.71
  3. Ashu Shah · 3 shared papers, 2021–2024 · strength 0.52
  4. Pranita Atri · 3 shared papers, 2021–2024 · strength 0.43
  5. Koelina Ganguly · 2 shared papers, 2021–2024 · strength 0.32
  6. Sanchita Rauth · 2 shared papers, 2021–2024 · strength 0.32
  7. Maneesh Jain · 2 shared papers, 2022–2024 · strength 0.32
  8. Rakesh Bhatia · 2 shared papers, 2021 · strength 0.24
  9. Lynette M. Smith · 2 shared papers, 2021–2022 · strength 0.23
  10. Parthasarathy Seshacharyulu · 2 shared papers, 2021–2022 · strength 0.22
  11. Chi H. Lin · 2 shared papers, 2021–2022 · strength 0.22
  12. Rama Krishna Nimmakayala · 2 shared papers, 2021–2022 · strength 0.22
  13. Christopher M. Thompson · 2 shared papers, 2019–2021 · strength 0.22
  14. Imran Khan · 1 shared paper, 2024 · strength 0.21
  15. Apar Kishor Ganti · 1 shared paper, 2024 · strength 0.21
  16. Satyanarayana Rachagani · 2 shared papers, 2019–2022 · strength 0.20
  17. Rahat Jahan · 1 shared paper, 2024 · strength 0.20
  18. Palanisamy Nallasamy · 1 shared paper, 2024 · strength 0.20
  19. Jesse L. Cox · 1 shared paper, 2024 · strength 0.20
  20. Sophia G. Kisling · 1 shared paper, 2024 · strength 0.20
  21. Muzafar Ahmad Macha · 1 shared paper, 2024 · strength 0.20
  22. Andrew C. Cannon · 1 shared paper, 2021 · strength 0.12
  23. Aneesha Dasgupta · 1 shared paper, 2018 · strength 0.12
  24. Venugopal Gunda · 1 shared paper, 2018 · strength 0.12
  25. Pankaj Kumar Singh · 1 shared paper, 2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.